Carglumic Acid-impurities | Pharmaffiliates

carglumic acid

Carglumic acid is used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. It is an orphan drug, marketed by Orphan Europe under the trade name Carbaglu. Reference standards of Carglumic Acid API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

No Data Found